Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1985 1
1988 1
1989 1
1990 2
1991 1
1992 1
1993 2
1994 1
1996 2
1997 2
1998 1
1999 3
2001 3
2002 2
2003 4
2004 3
2005 8
2006 2
2007 3
2008 4
2009 6
2010 3
2011 9
2012 14
2013 6
2014 8
2015 12
2016 16
2017 11
2018 11
2019 14
2020 10
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21896830

147 results
Results by year
Filters applied: . Clear all
Page 1
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.
Monico CG, Rossetti S, Belostotsky R, Cogal AG, Herges RM, Seide BM, Olson JB, Bergstrahl EJ, Williams HJ, Haley WE, Frishberg Y, Milliner DS. Monico CG, et al. Clin J Am Soc Nephrol. 2011 Sep;6(9):2289-95. doi: 10.2215/CJN.02760311. Clin J Am Soc Nephrol. 2011. PMID: 21896830 Free PMC article.
Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.
Fang X, He L, Xu G, Lin H, Xu M, Geng H. Fang X, et al. Pediatr Nephrol. 2019 Oct;34(10):1785-1790. doi: 10.1007/s00467-019-04279-7. Epub 2019 May 23. Pediatr Nephrol. 2019. PMID: 31123811
Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.
Milliner DS, Wilson DM, Smith LH. Milliner DS, et al. Kidney Int. 2001 Jan;59(1):31-6. doi: 10.1046/j.1523-1755.2001.00462.x. Kidney Int. 2001. PMID: 11135054 Free article.
Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III.
Ventzke A, Feldkötter M, Wei A, Becker J, Beck BB, Hoppe B. Ventzke A, et al. Pediatr Nephrol. 2017 Dec;32(12):2263-2271. doi: 10.1007/s00467-017-3731-3. Epub 2017 Jul 15. Pediatr Nephrol. 2017. PMID: 28711958
Late diagnosis of primary hyperoxaluria type III.
Richard E, Blouin JM, Harambat J, Llanas B, Bouchet S, Acquaviva C, de la Faille R. Richard E, et al. Ann Clin Biochem. 2017 May;54(3):406-411. doi: 10.1177/0004563216677101. Epub 2017 Jan 10. Ann Clin Biochem. 2017. PMID: 27742850
Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.
Belostotsky R, Pitt JJ, Frishberg Y. Belostotsky R, et al. J Mol Med (Berl). 2012 Dec;90(12):1497-504. doi: 10.1007/s00109-012-0930-z. Epub 2012 Jun 24. J Mol Med (Berl). 2012. PMID: 22729392
Cellular degradation of 4-hydroxy-2-oxoglutarate aldolase leads to absolute deficiency in primary hyperoxaluria type 3.
MacDonald JR, Huang AD, Loomes KM. MacDonald JR, et al. FEBS Lett. 2016 May;590(10):1467-76. doi: 10.1002/1873-3468.12181. Epub 2016 May 10. FEBS Lett. 2016. PMID: 27096395 Free article.
Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies.
Beck BB, Baasner A, Buescher A, Habbig S, Reintjes N, Kemper MJ, Sikora P, Mache C, Pohl M, Stahl M, Toenshoff B, Pape L, Fehrenbach H, Jacob DE, Grohe B, Wolf MT, Nürnberg G, Yigit G, Salido EC, Hoppe B. Beck BB, et al. Eur J Hum Genet. 2013 Feb;21(2):162-72. doi: 10.1038/ejhg.2012.139. Epub 2012 Jul 11. Eur J Hum Genet. 2013. PMID: 22781098 Free PMC article.
HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients.
M'dimegh S, Aquaviva-Bourdain C, Omezzine A, Souche G, M'barek I, Abidi K, Gargah T, Abroug S, Bouslama A. M'dimegh S, et al. J Clin Lab Anal. 2017 May;31(3):e22053. doi: 10.1002/jcla.22053. Epub 2016 Aug 26. J Clin Lab Anal. 2017. PMID: 27561601 Free PMC article.
[13C2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria.
Sikora P, von Unruh GE, Beck B, Feldkötter M, Zajaczkowska M, Hesse A, Hoppe B. Sikora P, et al. Kidney Int. 2008 May;73(10):1181-6. doi: 10.1038/ki.2008.63. Epub 2008 Mar 12. Kidney Int. 2008. PMID: 18337715 Free article.
147 results
Jump to page
Feedback